Royal Bank of Canada’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $317M | Buy |
3,501,447
+1,054,448
| +43% | +$88.3M | 0.05% | 333 |
|
|
2026
Q1 | $196M | Buy |
2,446,999
+375,801
| +18% | +$31M | 0.03% | 413 |
|
|
2025
Q4 | $177M | Sell |
2,071,198
-291,987
| -12% | -$24M | 0.03% | 460 |
|
|
2025
Q3 | $184M | Sell |
2,363,185
-873,662
| -27% | -$68.3M | 0.03% | 458 |
|
|
2025
Q2 | $253M | Buy |
3,236,847
+1,265,508
| +64% | +$94.4M | 0.05% | 328 |
|
|
2025
Q1 | $143M | Sell |
1,971,339
-316,342
| -14% | -$22.6M | 0.03% | 433 |
|
|
2024
Q4 | $169M | Buy |
2,287,681
+315,968
| +16% | +$22.1M | 0.03% | 405 |
|
|
2024
Q3 | $130M | Sell |
1,971,713
-491,970
| -20% | -$35.7M | 0.03% | 481 |
|
|
2024
Q2 | $228M | Sell |
2,463,683
-257,649
| -9% | -$22.8M | 0.05% | 302 |
|
|
2024
Q1 | $260M | Buy |
2,721,332
+59,249
| +2% | +$4.98M | 0.06% | 283 |
|
|
2023
Q4 | $203M | Sell |
2,662,083
-1,334,940
| -33% | -$92.9M | 0.05% | 329 |
|
|
2023
Q3 | $277M | Sell |
3,997,023
-698,748
| -15% | -$56.2M | 0.08% | 243 |
|
|
2023
Q2 | $443M | Buy |
4,695,771
+226,787
| +5% | +$19.7M | 0.12% | 163 |
|
|
2023
Q1 | $370M | Sell |
4,468,984
-348,205
| -7% | -$27.4M | 0.1% | 172 |
|
|
2022
Q4 | $359M | Sell |
4,817,189
-37,343
| -0.8% | -$2.88M | 0.1% | 185 |
|
|
2022
Q3 | $401M | Sell |
4,854,532
-434,004
| -8% | -$41.8M | 0.13% | 158 |
|
|
2022
Q2 | $503M | Sell |
5,288,536
-833,153
| -14% | -$86.3M | 0.15% | 135 |
|
|
2022
Q1 | $721M | Sell |
6,121,689
-379,528
| -6% | -$42.6M | 0.18% | 113 |
|
|
2021
Q4 | $842M | Sell |
6,501,217
-13,588
| -0.2% | -$1.58M | 0.19% | 108 |
|
|
2021
Q3 | $738M | Sell |
6,514,805
-8,160
| -0.1% | -$931K | 0.19% | 105 |
|
|
2021
Q2 | $676M | Buy |
6,522,965
+445,786
| +7% | +$42M | 0.18% | 115 |
|
|
2021
Q1 | $508M | Sell |
6,077,179
-697
| -0% | -$58.9K | 0.15% | 129 |
|
|
2020
Q4 | $554M | Buy |
6,077,876
+43,762
| +0.7% | +$3.63M | 0.16% | 130 |
|
|
2020
Q3 | $482M | Buy |
6,034,114
+825,011
| +16% | +$64.4M | 0.17% | 130 |
|
|
2020
Q2 | $360M | Buy |
5,209,103
+226,697
| +5% | +$16.1M | 0.14% | 144 |
|
|
2020
Q1 | $313M | Buy |
4,982,406
+541,932
| +12% | +$39.1M | 0.15% | 130 |
|
|
2019
Q4 | $345M | Sell |
4,440,474
-433,956
| -9% | -$33.9M | 0.12% | 151 |
|
|
2019
Q3 | $357M | Sell |
4,874,430
-78,090
| -2% | -$5.49M | 0.14% | 141 |
|
|
2019
Q2 | $305M | Buy |
4,952,520
+331,491
| +7% | +$20M | 0.12% | 154 |
|
|
2019
Q1 | $295M | Buy |
4,621,029
+238,170
| +5% | +$13.6M | 0.13% | 158 |
|
|
2018
Q4 | $224M | Sell |
4,382,859
-252,828
| -5% | -$12.8M | 0.11% | 167 |
|
|
2018
Q3 | $269M | Buy |
4,635,687
+130,119
| +3% | +$6.36M | 0.11% | 155 |
|
|
2018
Q2 | $219M | Sell |
4,505,568
-145,563
| -3% | -$6.79M | 0.1% | 180 |
|
|
2018
Q1 | $216M | Buy |
4,651,131
+387,108
| +9% | +$16.8M | 0.1% | 175 |
|
|
2017
Q4 | $160M | Buy |
4,264,023
+294,831
| +7% | +$10.8M | 0.07% | 240 |
|
|
2017
Q3 | $145M | Buy |
3,969,192
+9,648
| +0.2% | +$368K | 0.07% | 244 |
|
|
2017
Q2 | $156M | Buy |
3,959,544
+26,838
| +0.7% | +$980K | 0.08% | 205 |
|
|
2017
Q1 | $123M | Buy |
3,932,706
+426,747
| +12% | +$13.4M | 0.07% | 243 |
|
|
2016
Q4 | $110M | Buy |
3,505,959
+64,008
| +2% | +$2.07M | 0.06% | 276 |
|
|
2016
Q3 | $138M | Buy |
3,441,951
+1,674
| +0% | +$63K | 0.08% | 212 |
|
|
2016
Q2 | $114M | Sell |
3,440,277
-97,809
| -3% | -$3.35M | 0.07% | 228 |
|
|
2016
Q1 | $104M | Buy |
3,538,086
+154,857
| +5% | +$4.27M | 0.06% | 236 |
|
|
2015
Q4 | $89.1M | Buy |
3,383,229
+2,085,225
| +161% | +$54.1M | 0.06% | 268 |
|
|
2015
Q3 | $30.8M | Buy |
1,298,004
+418,800
| +48% | +$10.1M | 0.02% | 546 |
|
|
2015
Q2 | $20.9M | Buy |
879,204
+42,408
| +5% | +$957K | 0.01% | 795 |
|
|
2015
Q1 | $19.9M | Sell |
836,796
-119,304
| -12% | -$2.68M | 0.01% | 824 |
|
|
2014
Q4 | $20.3M | Buy |
956,100
+280,170
| +41% | +$5.63M | 0.01% | 850 |
|
|
2014
Q3 | $11.5M | Buy |
675,930
+245,262
| +57% | +$3.87M | 0.01% | 1122 |
|
|
2014
Q2 | $6.16M | Sell |
430,668
-19,110
| -4% | -$259K | ﹤0.01% | 1501 |
|
|
2014
Q1 | $5.56M | Sell |
449,778
-152,208
| -25% | -$1.76M | ﹤0.01% | 1487 |
|
|
2013
Q4 | $6.6M | Buy |
601,986
+45,084
| +8% | +$508K | ﹤0.01% | 1466 |
|
|
2013
Q3 | $6.46M | Sell |
556,902
-81,648
| -13% | -$955K | 0.01% | 1414 |
|
|
2013
Q2 | $7.15M | Buy |
+638,550
| New | +$7.56M | 0.01% | 1225 |
|
Other funds holding EW
Royal Bank of Canada's EW Position: Q2 2026 in Review
Royal Bank of Canada increased its Edwards Lifesciences (EW) stake by 43% in Q2 2026, buying an estimated $88.3M and bringing the position to 3,501,447 shares worth $317M. The position accounts for 0.05% of the portfolio, ranked #333.
Royal Bank of Canada first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $842M in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Royal Bank of Canada held 3,501,447 shares of Edwards Lifesciences worth $317M as of Q2 2026.
- Royal Bank of Canada bought 1,054,448 Edwards Lifesciences shares in Q2 2026, an estimated $88.3M.
- Edwards Lifesciences made up 0.05% of Royal Bank of Canada's portfolio in Q2 2026, its #333 holding.
- Royal Bank of Canada first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Edwards Lifesciences position peaked at $842M in Q4 2021.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.